y 27632 has been researched along with fosbretabulin in 2 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (fosbretabulin) | Trials (fosbretabulin) | Recent Studies (post-2010) (fosbretabulin) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 588 | 21 | 310 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akerman, S; Fisher, M; Kanthou, C; Mukherjee, D; Reyes-Aldasoro, CC; Tozer, GM; Williams, LJ | 1 |
| Defant, A; Mancini, I | 1 |
2 other study(ies) available for y 27632 and fosbretabulin
| Article | Year |
|---|---|
An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate.
Topics: Amides; Animals; Antineoplastic Agents, Phytogenic; Blood Pressure; Colorectal Neoplasms; Female; Humans; Male; Mice, SCID; Peroxidase; Pyridines; rho-Associated Kinases; Stilbenes | 2014 |
Design, Synthesis and Cancer Cell Growth Inhibition Evaluation of New Aminoquinone Hybrid Molecules.
Topics: Amides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Naphthoquinones; Neoplasms; Podophyllotoxin; Pyridines; Quinolines; rho-Associated Kinases; Stilbenes; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tubulin; Tubulin Modulators | 2019 |